Ï㽶ÊÓƵ

Dipayan Chaudhuri
No Rating Available
(Learn About Our Rating System)

Dipayan Chaudhuri, MD, PhD

Languages spoken: English, Spanish

Clinical Locations

Ï㽶ÊÓƵ of Utah Hospital

Salt Lake City
801-585-7676

  • Dr. Dipayan Chaudhuri earned his medical and graduate degrees at the Johns Hopkins Ï㽶ÊÓƵ School of Medicine. He then completed a residency in internal medicine at the Ï㽶ÊÓƵ of California, San Francisco and subsequently a clinical fellowship in Cardiovascular Diseases at the Massachusetts General Hospital. Concurrently with his clinical fellowship, he completed a postdoctoral research fellowship at Massachusetts General Hospital and Boston Children’s Hospital. Dr. Chaudhuri joined the faculty of the Cardiovascular Division at the Ï㽶ÊÓƵ of Utah in January 2016 as an Assistant Professor. He is also an investigator at the Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI) on the Health Sciences Campus. His research focuses on changes in metabolism during heart failure. Dr. Chaudhuri is an attending physician on the Cardiovascular Medical Unit and on the Cardiology Consult Service at the Ï㽶ÊÓƵ of Utah Hospital, with a clinical specialty in General Cardiology.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    National Board of Echocardiography

  • Dr. Dipayan Chaudhuri earned his medical and graduate degrees at the Johns Hopkins Ï㽶ÊÓƵ School of Medicine. He then completed a residency in internal medicine at the Ï㽶ÊÓƵ of California, San Francisco and subsequently a clinical fellowship in Cardiovascular Diseases at the Massachusetts General Hospital. Concurrently with his clinical fellowship, he completed a postdoctoral research fellowship at Massachusetts General Hospital and Boston Children’s Hospital. Dr. Chaudhuri joined the faculty of the Cardiovascular Division at the Ï㽶ÊÓƵ of Utah in January 2016 as an Assistant Professor. He is also an investigator at the Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI) on the Health Sciences Campus. His research focuses on changes in metabolism during heart failure. Dr. Chaudhuri is an attending physician on the Cardiovascular Medical Unit and on the Cardiology Consult Service at the Ï㽶ÊÓƵ of Utah Hospital, with a clinical specialty in General Cardiology.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Biochemistry -Adjunct
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    National Board of Echocardiography

    Education history

    Research Fellow Cardiology - Boston Children’s Hospital Research Fellow
    Cardiovascular Research Center - Massachusetts General Hospital Research Fellow
    Fellowship Cardiovascular Diseases - Massachusetts General Hospital Clinical Fellow
    Internal Medicine, ABIM Research Pathway - Ï㽶ÊÓƵ of California, San Francisco Resident
    Internship Internal Medicine - Ï㽶ÊÓƵ of California, San Francisco Intern
    Medicine, Neuroscience - Johns Hopkins Ï㽶ÊÓƵ School of Medicine M.D., Ph.D.
    Undergraduate Biology, Philosophy - Cornell Ï㽶ÊÓƵ B.A.

    Selected Publications

    Journal Article

    1. Visker JR, Cluntun AA, Velasco-Silva JN, Eberhardt DR, Cedeno-Rosario L, Shankar TS, Hamouche R, Ling J, Kwak H, Hillas JY, Aist I, Tseliou E, Navankasattusas S, Chaudhuri D, Ducker GS, Drakos SG, Rutter J (2024). Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart. JCI Insight. ()
    2. Atomwise AIMS Program (2024). AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep, 14(1), 7526.
    3. Szulik MW, Valdez S, Walsh M, Davis K, Bia R, Horiuchi E, OVery S, Laxman AK, Sandaklie-Nicolova L, Eberhardt DR, Durrant JR, Sheikh H, Hickenlooper S, Creed M, Brady C, Miller M, Wang L, Garcia-Llana J, Tracy C, Drakos SG, Funai K, Chaudhuri D, Boudina S, Franklin S (2023). SMYD1a protects the heart from ischemic injury by regulating OPA1-mediated cristae remodeling and supercomplex formation. Basic Res Cardiol, 118(1), 20. ()
    4. Johnson JM, Peterlin AD, Balderas E, Sustarsic EG, Maschek JA, Lang MJ, Jara-Ramos A, Panic V, Morgan JT, Villanueva CJ, Sanchez A, Rutter J, Lodhi IJ, Cox JE, Fisher-Wellman KH, Chaudhuri D, Gerhart-Hines Z, Funai K (2023). Mitochondrial phosphatidylethanolamine modulates UCP1 to promote brown adipose thermogenesis. Sci Adv, 9(8), eade7864. ()
    5. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri D (2022). Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nat Commun, 13(1), 2769. ()

    Review

    1. Balderas E, Lee SHJ, Rai NK, Mollinedo DM, Duron HE, Chaudhuri D (2024). Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease. [Review]. Physiology (Bethesda), 39(5). ()
    2. Lee SH, Duron HE, Chaudhuri D (2023). Beyond the TCA cycle: new insights into mitochondrial calcium regulation of oxidative phosphorylation. [Review]. Biochem Soc Trans, 51(4), 1661-1673. ()

    Book Chapter

    1. Balderas E, Sommakia S, Eberhardt D, Lee S, Chaudhuri D (2023). The structural era of the mitochondrial calcium uniporter. In Satin LS, Ben-Johny M, Dick IE (Eds.), Calcium Signals: From single molecules to physiology (pp. 12-1 to 12-22).

    Editorial

    1. Balderas E, Chaudhuri D (2023). Absence (of the uniporter) makes the heart grow fonder: The cardiac response to injury adapts after prolonged EMRE inhibition. J Mol Cell Cardiol, 181, 31-32. ()